ArticleClinical and translational science2022

Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients.

Susan Trümpelmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.